Please assess the completion status of the following clinical trial:

Trial Title: vMII for Measurement of Oesophageal Bolus Transport and Reflux

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* male or female~* at least 18 years of age~* have given informed consent for the vMII and Barium videofluoroscopy~* have symptoms of reflux, dysphagia, have known achalasia or are planned for anti-reflux surgery~Exclusion Criteria:~* with medications influencing gastrointestinal function within 3 days of the study~* with those on anticoagulants~* with any hematological abnormalities~* with any evidence of infectious disease~* who are pregnant or breast-feeding or sexually active and not on contraception.~* with evidence or history of drug or alcohol abuse within the past two years~* with diabetes mellitus~* with severe physical or mental health concerns on screening which may contribute to the ability to comply with study requirements~* with active co-morbid conditions~* with oesophageal surgery or stent (dilation acceptable)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Achalasia (Type: EXPERIMENTAL): Long vs Short Myotomy repair of Achalasia
- Dysphagia control (Type: EXPERIMENTAL): Conservative Management
- GORD for surgery (Type: EXPERIMENTAL): Partial vs Full Fundoplication repair
- GORD not for surgery (Type: EXPERIMENTAL): esomeprazole 40 mg vs no esomeprazole

Based on this trial design, predict the completion outcome and termination type (if applicable).